nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—FGFR2—cornea—refractive error	0.121	0.702	CbGeAlD
Thalidomide—NFKB1—eye—refractive error	0.0199	0.115	CbGeAlD
Thalidomide—CRBN—retina—refractive error	0.0165	0.0957	CbGeAlD
Thalidomide—FGFR2—eye—refractive error	0.015	0.0865	CbGeAlD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00263	0.00318	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00256	0.00309	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—ROBO3—refractive error	0.00255	0.00309	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—COL2A1—refractive error	0.00251	0.00303	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—PTEN—refractive error	0.00244	0.00295	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—SALL4—refractive error	0.00244	0.00294	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00238	0.00287	CbGpPWpGaD
Thalidomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00231	0.00279	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—PML—refractive error	0.0023	0.00278	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFITM2—refractive error	0.00227	0.00275	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—RNF111—refractive error	0.00227	0.00275	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—PDGFRA—refractive error	0.00225	0.00272	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—CACNA1D—refractive error	0.00224	0.0027	CbGpPWpGaD
Thalidomide—NFKB1—BCR signaling pathway—PTEN—refractive error	0.0022	0.00267	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFITM2—refractive error	0.00216	0.00261	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—RNF111—refractive error	0.00216	0.00261	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00215	0.0026	CbGpPWpGaD
Thalidomide—FGFR2—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00215	0.0026	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB4—PDGFRA—refractive error	0.00212	0.00256	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00209	0.00252	CbGpPWpGaD
Thalidomide—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00207	0.0025	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—CER1—refractive error	0.00204	0.00247	CbGpPWpGaD
Thalidomide—CYP2E1—Biological oxidations—CYP26A1—refractive error	0.00204	0.00246	CbGpPWpGaD
Thalidomide—CYP3A5—Biological oxidations—CYP26A1—refractive error	0.00203	0.00246	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—COL9A1—refractive error	0.00203	0.00245	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signal transduction—PDGFRA—refractive error	0.00202	0.00244	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR—PDGFRA—refractive error	0.00201	0.00243	CbGpPWpGaD
Thalidomide—CYP2E1—Metapathway biotransformation—CYP26A1—refractive error	0.00201	0.00243	CbGpPWpGaD
Thalidomide—CYP3A5—Metapathway biotransformation—CYP26A1—refractive error	0.00201	0.00242	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB2—PDGFRA—refractive error	0.002	0.00242	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 signaling—PDGFRA—refractive error	0.00199	0.00241	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00197	0.00239	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00196	0.00237	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00195	0.00236	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GREM2—refractive error	0.00194	0.00235	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CTSC—refractive error	0.00193	0.00234	CbGpPWpGaD
Thalidomide—CYP1A1—Biological oxidations—CYP26A1—refractive error	0.00192	0.00232	CbGpPWpGaD
Thalidomide—CYP1A1—Metapathway biotransformation—CYP26A1—refractive error	0.00189	0.00229	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00187	0.00226	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 interactions—PDGFRA—refractive error	0.00187	0.00226	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR in disease—PDGFRA—refractive error	0.00187	0.00226	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00186	0.00225	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—PDGFRA—refractive error	0.00186	0.00224	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00185	0.00224	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GREM2—refractive error	0.00184	0.00223	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00184	0.00222	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CTSC—refractive error	0.00183	0.00222	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—PDGFRA—refractive error	0.00183	0.00221	CbGpPWpGaD
Thalidomide—NFKB1—B Cell Activation—PDGFRA—refractive error	0.00183	0.00221	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00178	0.00215	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00178	0.00215	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00178	0.00215	CbGpPWpGaD
Thalidomide—FGFR2—B Cell Activation—PDGFRA—refractive error	0.00173	0.0021	CbGpPWpGaD
Thalidomide—FGFR2—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.00171	0.00207	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—CACNA1D—refractive error	0.0017	0.00206	CbGpPWpGaD
Thalidomide—FGFR2—Disease—DSE—refractive error	0.00169	0.00205	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00166	0.00201	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CHN1—refractive error	0.00165	0.00199	CbGpPWpGaD
Thalidomide—FGFR2—Disease—RDH5—refractive error	0.00159	0.00193	CbGpPWpGaD
Thalidomide—CYP2C19—Biological oxidations—CYP26A1—refractive error	0.00157	0.0019	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CHN1—refractive error	0.00157	0.00189	CbGpPWpGaD
Thalidomide—CYP2C19—Metapathway biotransformation—CYP26A1—refractive error	0.00155	0.00187	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—COL9A1—refractive error	0.00155	0.00187	CbGpPWpGaD
Thalidomide—FGFR2—PI-3K cascade—PTEN—refractive error	0.00154	0.00187	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00152	0.00183	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PCCA—refractive error	0.00151	0.00183	CbGpPWpGaD
Thalidomide—FGFR2—PI3K/AKT activation—PTEN—refractive error	0.00151	0.00182	CbGpPWpGaD
Thalidomide—FGFR2—GAB1 signalosome—PTEN—refractive error	0.00149	0.00181	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—PTEN—refractive error	0.00149	0.00181	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—OR2M7—refractive error	0.00147	0.00178	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00147	0.00178	CbGpPWpGaD
Thalidomide—FGFR2—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.00146	0.00177	CbGpPWpGaD
Thalidomide—CYP2C9—Biological oxidations—CYP26A1—refractive error	0.00143	0.00173	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00142	0.00171	CbGpPWpGaD
Thalidomide—CYP2C9—Metapathway biotransformation—CYP26A1—refractive error	0.00141	0.00171	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00141	0.0017	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00141	0.0017	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—OR2M7—refractive error	0.0014	0.00169	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00138	0.00167	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IPO5—refractive error	0.00138	0.00167	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—RNF111—refractive error	0.00138	0.00167	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—PAX6—refractive error	0.00135	0.00164	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—PDGFRA—refractive error	0.00134	0.00163	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—RNF111—refractive error	0.00131	0.00158	CbGpPWpGaD
Thalidomide—FGFR2—Disease—WNT10A—refractive error	0.00128	0.00155	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—PDGFRA—refractive error	0.00128	0.00154	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00125	0.00151	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00125	0.00151	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VIPR2—refractive error	0.00125	0.00151	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—CYP26A1—refractive error	0.00122	0.00148	CbGpPWpGaD
Thalidomide—CYP1A2—Metapathway biotransformation—CYP26A1—refractive error	0.00121	0.00146	CbGpPWpGaD
Thalidomide—FGFR2—Disease—RNF111—refractive error	0.00121	0.00146	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00121	0.00146	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VIPR2—refractive error	0.00119	0.00143	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00118	0.00143	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RDH5—refractive error	0.00118	0.00142	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CTSC—refractive error	0.00117	0.00142	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—EBP—refractive error	0.00117	0.00142	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—PTEN—refractive error	0.00115	0.00139	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Breast Cancer Pathway—PTEN—refractive error	0.00115	0.00139	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RDH5—refractive error	0.00112	0.00135	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—AXL—refractive error	0.00111	0.00135	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CTSC—refractive error	0.00111	0.00134	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling of activated FGFR—PTEN—refractive error	0.0011	0.00133	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB4—PTEN—refractive error	0.00109	0.00131	CbGpPWpGaD
Thalidomide—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.00106	0.00128	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—AXL—refractive error	0.00106	0.00128	CbGpPWpGaD
Thalidomide—FGFR2—Disease—LUM—refractive error	0.00105	0.00127	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signal transduction—PTEN—refractive error	0.00104	0.00125	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR—PTEN—refractive error	0.00103	0.00125	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—PAX6—refractive error	0.00103	0.00125	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB2—PTEN—refractive error	0.00103	0.00124	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00102	0.00124	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00102	0.00124	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 signaling—PTEN—refractive error	0.00102	0.00124	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VANGL2—refractive error	0.00102	0.00123	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00101	0.00123	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.00101	0.00122	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VANGL2—refractive error	0.000967	0.00117	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 interactions—PTEN—refractive error	0.000962	0.00116	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000962	0.00116	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR in disease—PTEN—refractive error	0.000962	0.00116	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000954	0.00115	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—PTEN—refractive error	0.000953	0.00115	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—WNT10A—refractive error	0.000948	0.00115	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—PTEN—refractive error	0.000945	0.00114	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—PTEN—refractive error	0.00094	0.00114	CbGpPWpGaD
Thalidomide—NFKB1—B Cell Activation—PTEN—refractive error	0.000938	0.00113	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000934	0.00113	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000934	0.00113	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—EBP—refractive error	0.00093	0.00112	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—WNT10A—refractive error	0.000899	0.00109	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RNF111—refractive error	0.000891	0.00108	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CER1—refractive error	0.000891	0.00108	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TJP2—refractive error	0.000891	0.00108	CbGpPWpGaD
Thalidomide—FGFR2—B Cell Activation—PTEN—refractive error	0.00089	0.00108	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DSE—refractive error	0.000888	0.00107	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—EBP—refractive error	0.000875	0.00106	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.000875	0.00106	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—EBP—refractive error	0.000873	0.00106	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000852	0.00103	CbGpPWpGaD
Thalidomide—FGFR2—Disease—RPS27—refractive error	0.000847	0.00102	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CER1—refractive error	0.000845	0.00102	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RNF111—refractive error	0.000845	0.00102	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TJP2—refractive error	0.000845	0.00102	CbGpPWpGaD
Thalidomide—PTGS2—Disease—DSE—refractive error	0.000841	0.00102	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—EBP—refractive error	0.000825	0.000998	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000798	0.000965	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000798	0.000965	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PLA2G16—refractive error	0.000791	0.000956	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PCCA—refractive error	0.000791	0.000956	CbGpPWpGaD
Thalidomide—PTGS2—Disease—RDH5—refractive error	0.000791	0.000956	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—PDGFRA—refractive error	0.000767	0.000927	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PML—refractive error	0.00075	0.000907	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PCCA—refractive error	0.00075	0.000907	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—PDGFRA—refractive error	0.000737	0.00089	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—PDGFRA—refractive error	0.000728	0.00088	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000727	0.000878	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PML—refractive error	0.000712	0.000861	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DSE—refractive error	0.000705	0.000852	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—PDGFRA—refractive error	0.000699	0.000845	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—PTEN—refractive error	0.00069	0.000835	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IPO5—refractive error	0.000686	0.000829	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—EBP—refractive error	0.000675	0.000816	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—COL9A1—refractive error	0.000675	0.000816	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DSE—refractive error	0.000663	0.000802	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DSE—refractive error	0.000662	0.0008	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—PTEN—refractive error	0.000655	0.000792	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—COL9A1—refractive error	0.000641	0.000775	CbGpPWpGaD
Thalidomide—PTGS2—Disease—WNT10A—refractive error	0.000638	0.000771	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PCCA—refractive error	0.000628	0.000759	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PLA2G16—refractive error	0.000628	0.000759	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DSE—refractive error	0.000625	0.000756	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—EBP—refractive error	0.000616	0.000744	CbGpPWpGaD
Thalidomide—PTGS2—Disease—RNF111—refractive error	0.0006	0.000725	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PLA2G16—refractive error	0.000591	0.000715	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PCCA—refractive error	0.000591	0.000715	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PCCA—refractive error	0.00059	0.000713	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PLA2G16—refractive error	0.00059	0.000713	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PLA2G16—refractive error	0.000557	0.000674	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PCCA—refractive error	0.000557	0.000674	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—LUM—refractive error	0.000548	0.000663	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CACNA1D—refractive error	0.000528	0.000638	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—EBP—refractive error	0.000526	0.000636	CbGpPWpGaD
Thalidomide—PTGS2—Disease—LUM—refractive error	0.00052	0.000628	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DSE—refractive error	0.000512	0.000619	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DSE—refractive error	0.000467	0.000564	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CYP26A1—refractive error	0.000466	0.000564	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—BMP2—refractive error	0.000463	0.000559	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PCCA—refractive error	0.000456	0.000551	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PLA2G16—refractive error	0.000456	0.000551	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000449	0.000543	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PDGFRA—refractive error	0.000447	0.00054	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—BMP2—refractive error	0.000439	0.000531	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—LUM—refractive error	0.000435	0.000526	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PDGFRA—refractive error	0.000424	0.000512	CbGpPWpGaD
Thalidomide—PTGS2—Disease—RPS27—refractive error	0.00042	0.000508	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CACNA1D—refractive error	0.000419	0.000507	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PLA2G16—refractive error	0.000416	0.000503	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PCCA—refractive error	0.000416	0.000503	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—LUM—refractive error	0.00041	0.000495	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—LUM—refractive error	0.000409	0.000494	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DSE—refractive error	0.000399	0.000482	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CACNA1D—refractive error	0.000394	0.000477	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—PTEN—refractive error	0.000394	0.000476	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CACNA1D—refractive error	0.000394	0.000476	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PDGFRA—refractive error	0.000391	0.000473	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—LUM—refractive error	0.000386	0.000467	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—PTEN—refractive error	0.000378	0.000457	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—PTEN—refractive error	0.000374	0.000452	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CACNA1D—refractive error	0.000372	0.00045	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CYP26A1—refractive error	0.00037	0.000447	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—PTEN—refractive error	0.000359	0.000434	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PLA2G16—refractive error	0.000355	0.00043	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PCCA—refractive error	0.000355	0.00043	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CYP26A1—refractive error	0.000348	0.000421	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CYP26A1—refractive error	0.000348	0.00042	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CYP26A1—refractive error	0.000329	0.000397	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—LUM—refractive error	0.000316	0.000382	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CACNA1D—refractive error	0.000304	0.000368	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PDGFRA—refractive error	0.000289	0.000349	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—LUM—refractive error	0.000288	0.000349	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CACNA1D—refractive error	0.000278	0.000335	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PDGFRA—refractive error	0.000274	0.000331	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CYP26A1—refractive error	0.000269	0.000325	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—LUM—refractive error	0.000246	0.000298	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CYP26A1—refractive error	0.000245	0.000296	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CACNA1D—refractive error	0.000237	0.000287	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000236	0.000286	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PTEN—refractive error	0.000229	0.000277	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PTEN—refractive error	0.000218	0.000263	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CYP26A1—refractive error	0.000209	0.000253	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTEN—refractive error	0.000201	0.000243	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PDGFRA—refractive error	0.000194	0.000235	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000188	0.000227	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000167	0.000201	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PTEN—refractive error	0.000148	0.000179	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PTEN—refractive error	0.000141	0.00017	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000136	0.000165	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000124	0.00015	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000106	0.000128	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTEN—refractive error	0.000105	0.000127	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PTEN—refractive error	9.98e-05	0.000121	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PTEN—refractive error	8.36e-05	0.000101	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTEN—refractive error	7.87e-05	9.51e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTEN—refractive error	7.85e-05	9.49e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTEN—refractive error	7.42e-05	8.97e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTEN—refractive error	6.07e-05	7.34e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTEN—refractive error	5.53e-05	6.69e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTEN—refractive error	4.73e-05	5.72e-05	CbGpPWpGaD
